HUTCHMED announced a webcast on November 5, 2026, to discuss recent Phase III clinical data for savolitinib in treating MET-driven non-small cell lung cancer (NSCLC). The event will feature insights from Professor Yi-Long Wu and Dr. Weiguo Su on treatment strategies and regulatory outlook based on studies SANOVO and SAFFRON. Savolitinib, marketed as ORPATHYS® in China, is a targeted therapy showing promising results in advanced NSCLC and other cancers. This webcast aims to inform analysts and investors about the drug’s clinical progress and future potential.
For readers following HUTCHMED's recent clinical data event on savolitinib, here is Pluang's health sector market snapshot as of Oct 27, 2026 04:12 WIB: Of 150 priced health-sector US stocks, 81 rose and 69 fell. Notable movers include CTXR at USD 0.45 with a 1-day change of +11.08% and Pluang order activity showing 94% Sell / 6% Buy, WGS at USD 60.07 up +6.98% with 42% Sell / 58% Buy, and INO at USD 0.89 up +6.44% with 13% Sell / 87% Buy. Typical hold times range from 18 to 43 days on Pluang.
Monteverde & Associates PC is investigating the fairness of proposed mergers involving Synaptics (SYNA), Eagle Financial Services (EFSI), Victory Capital Holdings (VCTR), and Centerspace (CSR). Shareholders are urged to consider if the deals are fair...
At the Cisco Partner Summit 2026, Presidio was honored as the Global Innovation Partner of the Year, recognizing its outstanding innovation and success in delivering impactful customer solutions. This award highlights Presidio's commitment to partner...
Presidio was awarded the Global Services and Software Excellence Partner of the Year at the Cisco Partner Summit 2026. This award recognizes Presidio's outstanding innovation and success in delivering solutions that help customers achieve meaningful ...
Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...
Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...
